Tags

Type your tag names separated by a space and hit enter

Seborrheic Dermatitis in Skin of Color: Clinical Considerations
J Drugs Dermatol. 2019 01 01; 18(1):24-27.JD

Abstract

Seborrheic dermatitis is a common, relapsing, inflammatory skin condition of unclear etiology. The Malassezia yeast genus are believed to play a role. Seborrheic dermatitis commonly affects areas of the skin with high sebum production, including the scalp, nasolabial folds, glabella, eyebrows, beard, ears, retroauricular skin, sternum, and other skin folds. Seborrheic dermatitis may present differently in individuals with skin of color. Darker-skinned individuals may present with scaly, hypopigmented macules and patches in typical areas of involvement. Arcuate or petal-like patches may be seen, specifically termed petaloid seborrheic dermatitis. Children of color often do not experience the classic “cradle cap” appearance of seborrheic dermatitis, and have erythema, flaking, and hypopigmentation of the affected areas and folds of skin. Seborrheic dermatitis tends to respond well to conventional treatments, although it tends to recur. Skin of color patients may require a modified treatment approach which takes into account differences in hair texture and hair washing frequency. This paper aims to highlight these differences to help reduce disparities in the management of seborrheic dermatitis in patients of color. J Drugs Dermatol. 2019;18(1):24-27.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

30681789

Citation

Elgash, May, et al. "Seborrheic Dermatitis in Skin of Color: Clinical Considerations." Journal of Drugs in Dermatology : JDD, vol. 18, no. 1, 2019, pp. 24-27.
Elgash M, Dlova N, Ogunleye T, et al. Seborrheic Dermatitis in Skin of Color: Clinical Considerations. J Drugs Dermatol. 2019;18(1):24-27.
Elgash, M., Dlova, N., Ogunleye, T., & Taylor, S. C. (2019). Seborrheic Dermatitis in Skin of Color: Clinical Considerations. Journal of Drugs in Dermatology : JDD, 18(1), 24-27.
Elgash M, et al. Seborrheic Dermatitis in Skin of Color: Clinical Considerations. J Drugs Dermatol. 2019 01 1;18(1):24-27. PubMed PMID: 30681789.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Seborrheic Dermatitis in Skin of Color: Clinical Considerations AU - Elgash,May, AU - Dlova,Ncoza, AU - Ogunleye,Temitayo, AU - Taylor,Susan C., PY - 2019/1/26/entrez PY - 2019/1/27/pubmed PY - 2019/2/13/medline SP - 24 EP - 27 JF - Journal of drugs in dermatology : JDD JO - J Drugs Dermatol VL - 18 IS - 1 N2 - Seborrheic dermatitis is a common, relapsing, inflammatory skin condition of unclear etiology. The Malassezia yeast genus are believed to play a role. Seborrheic dermatitis commonly affects areas of the skin with high sebum production, including the scalp, nasolabial folds, glabella, eyebrows, beard, ears, retroauricular skin, sternum, and other skin folds. Seborrheic dermatitis may present differently in individuals with skin of color. Darker-skinned individuals may present with scaly, hypopigmented macules and patches in typical areas of involvement. Arcuate or petal-like patches may be seen, specifically termed petaloid seborrheic dermatitis. Children of color often do not experience the classic “cradle cap” appearance of seborrheic dermatitis, and have erythema, flaking, and hypopigmentation of the affected areas and folds of skin. Seborrheic dermatitis tends to respond well to conventional treatments, although it tends to recur. Skin of color patients may require a modified treatment approach which takes into account differences in hair texture and hair washing frequency. This paper aims to highlight these differences to help reduce disparities in the management of seborrheic dermatitis in patients of color. J Drugs Dermatol. 2019;18(1):24-27. SN - 1545-9616 UR - https://www.unboundmedicine.com/medline/citation/30681789/Seborrheic_Dermatitis_in_Skin_of_Color:_Clinical_Considerations DB - PRIME DP - Unbound Medicine ER -